Search CommunityWalk:


CYNCA Laboratories Inc.

20 First Field Road
Gathersburg, MD, USA

Category: Bioinformatics/Genomics/Proteomics/Pharmacogenomics

Used in the following map:

Maryland Biotech Industry Map

CYNCA Laboratories Inc. is a biotech company with a mission of developing drugs against infectious and inflammatory diseases as well as a protein chip-based diagnosis and research tool. It was founded in 2004 with a goal of becoming a powerhouse of discovery and innovation on diagnosis and therapeutics.

CYNCA has developed a "two-step binding" technology for protein chip design. The technology can be used for the large-scale multiplex protein assay with high specificity and sensitivity. The technology provides the basis for design of various chip-based products for diagnosis and proteomic research applications. The company has also developed an in-vitro cell-based model for identification of disease-relevant small nucleotide polymorphism (SNP). This model combines in-vitro cell-based functional analysis from individual donors and identification of differential SNPs.

CYNCA's product pipeline includes: 1) CC301, a HIV-1 blocker to prevent HIV-1 infection; 2) CC401, a nature compound-derived drug for HIV-1/AIDS; 3) CC501, a protein chip for profiling secretory proteins; 4) CC502, a protein chip for profiling salivary proteins; and 5) CC601, a SNP assay for predicting individual response to sepsis.